Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer.
about
The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancerRecent advances of highly selective CDK4/6 inhibitors in breast cancerEmerging therapies for breast cancerMeta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemiamiR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation.Recent development of targeted approaches for the treatment of breast cancer.Strategies and Progress of Endocrine Therapy for Patients with Metastatic Breast Cancer.Non-canonical roles of PFKFB3 in regulation of cell cycle through binding to CDK4.Deciphering the binding behavior of flavonoids to the cyclin dependent kinase 6/cyclin D complex.Bcl-2 promotes metastasis through the epithelial-to-mesenchymal transition in the BCap37 medullary breast cancer cell line.Updates on managing advanced breast cancer with palbociclib combination therapyCurrent Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
P2860
Q26751387-039525F6-6DC8-4922-B675-450669FD0AA9Q33602076-1D9DF84D-4F77-4C8F-9C75-9E2EC5D9D06DQ33617949-BD7AB78C-F086-4C23-B54C-95E73E6D45DDQ36276060-270A2E0B-06AB-45AA-917F-AB2483E29B23Q37085995-A40D5AB1-917B-4529-90AF-12313EE35ED1Q38802191-0112F9DA-883C-40A2-8C70-0C962CEC49CAQ47561979-22EABC51-865E-486F-9A5F-61EBF1E338A1Q48536956-C60E87CD-561B-4458-B0BF-669BA253286DQ54979952-1D03B3DF-D62C-4308-ACF9-0F871EFBB618Q55241008-D4E8EC13-D7FB-43E1-AB41-917AC48286F3Q57106487-D38348AB-56C9-426A-B96F-19CB822DAB59Q57108041-DB958183-B211-43F8-9FB0-BC164213A29C
P2860
Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Palbociclib: a first-in-class ...... sitive advanced breast cancer.
@ast
Palbociclib: a first-in-class ...... sitive advanced breast cancer.
@en
type
label
Palbociclib: a first-in-class ...... sitive advanced breast cancer.
@ast
Palbociclib: a first-in-class ...... sitive advanced breast cancer.
@en
prefLabel
Palbociclib: a first-in-class ...... sitive advanced breast cancer.
@ast
Palbociclib: a first-in-class ...... sitive advanced breast cancer.
@en
P2860
P1476
Palbociclib: a first-in-class ...... sitive advanced breast cancer.
@en
P2093
P2860
P2888
P356
10.1186/S13045-015-0194-5
P577
2015-08-13T00:00:00Z
P5875
P6179
1016185148